FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022396274> ?p ?o ?g. }

• W2022396274 abstract "It is said that most cases detected by neuroblastoma mass screening at 6 months of age tend to have a favorable clinical course after a surgical resection either with or without mild chemotherapy. However, a few cases have an unfavorable outcome. In the current study, the authors analyzed the clinical and biologic characteristics for recurring neuroblastoma in mass screening cases.In 245 cases detected through mass screening in the Kyushu area in Japan, the clinical data and biologic features (N-myc status, DNA ploidy, Shimada histology, neuron-specific enolase (NSE), ferritin) were investigated, whereas, in particular, the data for recurring cases also were analyzed.Of 245 cases, 28 tumors had one or more biologically unfavorable prognostic factors, and 6 patients experienced recurrence. Three of the six patients with recurring disease underwent a complete resection of the primary tumor, whereas three cases had undergone an incomplete resection of the tumor. Regarding the initial chemotherapy, three cases received mild chemotherapy, two cases received no chemotherapy, and one case had high-dose multidrug chemotherapy. Regarding biologic prognostic factors, four of six cases with recurring disease had one or more unfavorable factors, whereas two cases had no unfavorable factors. Regarding the outcome after recurrence, four cases are CR, one case has a stable residual tumor, and one case died of disease with N-myc amplification.Most neuroblastomas detected by mass screening at 6 months of age have biologically favorable factors. However, approximately 10% of the cases had one or more unfavorable factors and thus might have a higher risk of recurrence than the patients with no unfavorable factors. Conversely, some cases with recurring disease had no unfavorable factors; however, the reason for this is still unclear. A long-term follow-up for mass screening cases is important, and it also might be necessary to research the established biologic factors and identify other new prognostic factors." @default.
• W2022396274 created "2016-06-24" @default.
• W2022396274 creator A5008271696 @default.
• W2022396274 creator A5008359331 @default.
• W2022396274 creator A5017118266 @default.
• W2022396274 creator A5023572058 @default.
• W2022396274 creator A5023834571 @default.
• W2022396274 creator A5025082835 @default.
• W2022396274 creator A5028856515 @default.
• W2022396274 creator A5034303379 @default.
• W2022396274 creator A5035566366 @default.
• W2022396274 creator A5037477184 @default.
• W2022396274 creator A5044063280 @default.
• W2022396274 creator A5052036955 @default.
• W2022396274 creator A5053759966 @default.
• W2022396274 creator A5054715205 @default.
• W2022396274 creator A5066213912 @default.
• W2022396274 date "2001-01-01" @default.
• W2022396274 modified "2023-09-29" @default.
• W2022396274 title "Clinical and biologic characteristics for recurring neuroblastoma at mass screening cases in Japan" @default.
• W2022396274 cites W1926885922 @default.
• W2022396274 cites W1982343324 @default.
• W2022396274 cites W2002314852 @default.
• W2022396274 cites W2010423525 @default.
• W2022396274 cites W2012219845 @default.
• W2022396274 cites W2018958767 @default.
• W2022396274 cites W2034491014 @default.
• W2022396274 cites W2046300584 @default.
• W2022396274 cites W2056865644 @default.
• W2022396274 cites W2059090231 @default.
• W2022396274 cites W2071488635 @default.
• W2022396274 cites W2075740912 @default.
• W2022396274 cites W2085102102 @default.
• W2022396274 cites W2329506722 @default.
• W2022396274 cites W2330923897 @default.
• W2022396274 cites W2887651337 @default.
• W2022396274 cites W947041447 @default.
• W2022396274 doi "https://doi.org/10.1002/1097-0142(20010715)92:2<349::aid-cncr1329>3.0.co;2-c" @default.
• W2022396274 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11466689" @default.
• W2022396274 hasPublicationYear "2001" @default.
• W2022396274 type Work @default.
• W2022396274 sameAs 2022396274 @default.
• W2022396274 citedByCount "13" @default.
• W2022396274 countsByYear W20223962742012 @default.
• W2022396274 crossrefType "journal-article" @default.
• W2022396274 hasAuthorship W2022396274A5008271696 @default.
• W2022396274 hasAuthorship W2022396274A5008359331 @default.
• W2022396274 hasAuthorship W2022396274A5017118266 @default.
• W2022396274 hasAuthorship W2022396274A5023572058 @default.
• W2022396274 hasAuthorship W2022396274A5023834571 @default.
• W2022396274 hasAuthorship W2022396274A5025082835 @default.
• W2022396274 hasAuthorship W2022396274A5028856515 @default.
• W2022396274 hasAuthorship W2022396274A5034303379 @default.
• W2022396274 hasAuthorship W2022396274A5035566366 @default.
• W2022396274 hasAuthorship W2022396274A5037477184 @default.
• W2022396274 hasAuthorship W2022396274A5044063280 @default.
• W2022396274 hasAuthorship W2022396274A5052036955 @default.
• W2022396274 hasAuthorship W2022396274A5053759966 @default.
• W2022396274 hasAuthorship W2022396274A5054715205 @default.
• W2022396274 hasAuthorship W2022396274A5066213912 @default.
• W2022396274 hasConcept C126322002 @default.
• W2022396274 hasConcept C141071460 @default.
• W2022396274 hasConcept C143998085 @default.
• W2022396274 hasConcept C2776694085 @default.
• W2022396274 hasConcept C2776715637 @default.
• W2022396274 hasConcept C2779134260 @default.
• W2022396274 hasConcept C54355233 @default.
• W2022396274 hasConcept C71924100 @default.
• W2022396274 hasConcept C81885089 @default.
• W2022396274 hasConcept C86803240 @default.
• W2022396274 hasConceptScore W2022396274C126322002 @default.
• W2022396274 hasConceptScore W2022396274C141071460 @default.
• W2022396274 hasConceptScore W2022396274C143998085 @default.
• W2022396274 hasConceptScore W2022396274C2776694085 @default.
• W2022396274 hasConceptScore W2022396274C2776715637 @default.
• W2022396274 hasConceptScore W2022396274C2779134260 @default.
• W2022396274 hasConceptScore W2022396274C54355233 @default.
• W2022396274 hasConceptScore W2022396274C71924100 @default.
• W2022396274 hasConceptScore W2022396274C81885089 @default.
• W2022396274 hasConceptScore W2022396274C86803240 @default.
• W2022396274 hasLocation W20223962741 @default.
• W2022396274 hasLocation W20223962742 @default.
• W2022396274 hasOpenAccess W2022396274 @default.
• W2022396274 hasPrimaryLocation W20223962741 @default.
• W2022396274 hasRelatedWork W1728332092 @default.
• W2022396274 hasRelatedWork W1978128249 @default.
• W2022396274 hasRelatedWork W1980910725 @default.
• W2022396274 hasRelatedWork W1995294036 @default.
• W2022396274 hasRelatedWork W2014140797 @default.
• W2022396274 hasRelatedWork W2014652724 @default.
• W2022396274 hasRelatedWork W2019137723 @default.
• W2022396274 hasRelatedWork W2025990081 @default.
• W2022396274 hasRelatedWork W2028167521 @default.
• W2022396274 hasRelatedWork W2036436065 @default.
• W2022396274 hasRelatedWork W2053263137 @default.
• W2022396274 hasRelatedWork W2064000610 @default.
• W2022396274 hasRelatedWork W2095310757 @default.
• W2022396274 hasRelatedWork W2111900445 @default.
• W2022396274 hasRelatedWork W2141217323 @default.
• W2022396274 hasRelatedWork W2160604042 @default.

• next